WINREVAIR DIN 02551314
Status: Marketed
Holder: MERCK CANADA INC
Health Canada record
| Active ingredient(s) | SOTATERCEPT 60 MG |
|---|
| Dosage form | Kit; Powder For Solution |
|---|
| Route | Subcutaneous |
|---|
| Schedule | SCHEDULE D; PRESCRIPTION |
|---|
| Class | Human |
|---|
| ATC | C02KX06 SOTATERCEPT |
|---|
| Original market date | 12-Feb-2025 |
|---|
| Current status date | 12-Feb-2025 |
|---|
| Source | Health Canada DPD |
|---|
Establishment licence of the holder
Merck Canada Inc — licence 101380, currently licensed, last inspection rating C (2023-07-17).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing SOTATERCEPT
| DIN | Product | Company | Form | Strength | Status |
|---|
| 02551284 | WINREVAIR | MERCK CANADA INC | Powder For Solution | SOTATERCEPT 45 MG | Approved |
| 02551292 | WINREVAIR | MERCK CANADA INC | Powder For Solution | SOTATERCEPT 60 MG | Approved |
| 02551306 | WINREVAIR | MERCK CANADA INC | Kit; Powder For Solution | SOTATERCEPT 45 MG | Marketed |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|
| 33928 | 2024-08-28 | New Drug Submission (NDS) | |
Request a quote for WINREVAIR
How to read a Canadian DIN record